Survival
infection, death
INFECTION
Two IGIV-treated animals which succumbed to infection did not meet the criteria for inclusion in the MITT set of animals and were excluded from survival analysis. ANTHRASIL significantly enhanced survival (p = 0.0009, Fisher’s exact test) in the MITT set of animals group (26%, 13 of 50) compared to the IGIV group (2%, 1 of 48); ANTHRASIL also increased time to death compared to the IGIV group (p < 0.0001, log-rank test) (